The Evidence Stack: We Benchmarked our ML Powered Research Synthesis Platform Against the Most Studied Drugs on Earth

Periscopic Labs · March 2026

We’re opening the waitlist for Discovery Synth today. If you work in Biotech, Pharma, Clinical research, Health Economics or Health technology - or if you’re an ML researcher or engineer who wants to work on problems that actually matter - we’d love to hear from you. → Join the waitlist at Discovery Synth → Full benchmark report at Benchmark-Discovery-Synth It’s 2:00 AM. A researcher at a mid-size biotech is sitting in front of 47 open browser tabs - PubMed, ClinicalTrials.gov, three Cochrane reviews, a half-downloaded PDF from NEJM, a UniProt page she opened four hours ago and hasn’t…

related reading

• Gap Mapgap-map.org
• Physicians Answer More Clinical Questions and Change Clinical Decisions More Often With Synthesized Evidence: A Randomized Trial in Primary Care - PMCncbi.nlm.nih.gov
• The ML drug discovery startup trying really, really hard to not cheat (Leash Bio)owlposting.com
• The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
• Sci-Hubsci-hub.box
• Life sciences | Deloitte Insightswww2.deloitte.com
• TorchDrug: A Powerful and Flexible Machine Learning Platform for Drug Discoveryarxiv.org
• AI-Powered Drug Discovery Platform | Deep Origindeeporigin.com
• Where are all the trillion dollar biotechs?ladanuzhna.xyz
• Practical Cheminformatics Index - Practical Cheminformaticspatwalters.github.io
• Systematic integration of biomedical knowledge prioritizes drugs for repurposinggit.dhimmel.com
• The 23andMe Deal - Cremieux Recueilcremieux.xyz